Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.27 – $0.33
100% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.9M | $9.6M | $10.4M | $11.9M | $12.5M | $13.8M | $16.5M | $17.5M |
| Cost of revenue | $1.4M | $2.1M | $2.3M | $3.4M | $4.0M | $3.0M | $3.4M | $4.2M |
| Gross profit | $5.5M | $7.5M | $8.1M | $8.5M | $8.5M | $10.8M | $13.1M | $13.2M |
| Gross margin | 79.2% | 78.5% | 77.7% | 71.5% | 68.2% | 78.1% | 79.6% | 75.9% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$768.0K | −$123.7K | $1.5M | $2.2M | $79.4K | −$143.9K | $1.2M | $1.8M |
| EBITDA | −$436.4K | $951.5K | $2.5M | $4.3M | $1.7M | $1.0M | $2.3M | $3.0M |
| Net income | −$694.7K | −$213.6K | $2.1M | $4.0M | −$22.2K | −$332.0K | $614.6K | $1.3M |
| Net margin | -10.0% | -2.2% | 20.4% | 34.1% | -0.2% | -2.4% | 3.7% | 7.4% |
| EPS (diluted) | -0.01 | -0.00 | 0.03 | 0.05 | -0.00 | -0.00 | 0.01 | 0.01 |
Annual figures · source: Financial Modeling Prep
NEXGENRX INC
No one on the platform currently holds NEGXF.
No tracked institution reports a position in NEGXF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-04-24 | $0.0050 | 2026-04-28 |
| 2025-12-17 | $0.0050 | 2025-12-19 |
| 2025-08-25 | $0.0050 | 2025-08-29 |
| 2025-04-25 | $0.0050 | 2025-04-30 |
| 2024-12-16 | $0.0050 | 2024-12-20 |
| 2024-06-24 | $0.0050 | 2024-06-30 |
| 2023-12-28 | $0.0050 | 2024-01-04 |
No one on the platform has traded NEGXF yet.
| $15M |
| — |
| PXXLFPoxel S.A. | $0.26 | +0.00% | $16M | — |
| RAMMFRAMM Pharma Corp. | $0.06 | +0.00% | $15M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 1.3× sales vs its 1.1× historical median P/S.
Fair value ≈ $0.27 · price $0.33 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.